Specialty Pharmacy

Top news of the day from across the health care landscape.

Officials with the Centers for Medicare & Medicaid Services this week proposed requiring drug manufacturers to include prices in direct-to-consumer television advertisements for prescription drugs.

Recent preclinical and population evidence shows cannabis modulates inflammatory and fibrotic processes in the liver, which is promising for treating the symptoms of hepatitis C virus.

Talazoparib is indicated for patients with known deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic breast cancer.

Aspirin dose and duration of use may affect the risk of developing ovarian cancer and hepatocellular cancer.

Neoadjuvant therapy with a combination checkpoint blockade produced a high response rate among patients with melanoma.

Top news of the day from across the health care landscape.

Study investigates whether direct-acting antiviral drugs for hepatitis C virus increase the risk of developing hepatocellular carcinoma.

The benefits of adopting blockchain technology have not been overlooked by the health care industry and can have a direct and lasting impact on specialty pharmacy.

Obesity and weight gain in early adulthood may be a contributor to increased risk of early-onset colorectal cancer in women under the age of 50.

Mike Agostino, RPh, President of the National Association of Specialty Pharmacy (NASP), discusses how NASP has grown to meet the evolving needs of the pharmacy profession.

Top news of the day from across the health care landscape.

Fingolimod (Gilenya) found to significantly reduce the annualized relapse rate compared with glatiramer acetate among patients with relapsing-remitting multiple sclerosis.

On the first National Women Pharmacists Day, top voices in the field discuss how women are helping to shape the future of pharmacy.

Top news of the day from across the health care landscape.

A look at last week's top stories in the world of pharmacy.

Puerto Rico’s Hispanic population faces substantially different cancer risks compared with Hispanics in the continental United States.

Top news of the day from across the health care landscape.

Researchers investigated the impact of individual types of human papilloma virus on HIV acquisition.

New 5-year data from phase 3 studies show that patients treated earlier with ocrelizumab (Ocrevus) had better outcomes on multiple measures of multiple sclerosis disease activity.

The national Veterans Health Administration Corporate Data Warehouse could be key in revealing accurate data on the use of direct-acting antivirals in the treatment of chronic hepatitis C virus.

Insurers and pharmacy benefit managers can no longer restrict pharmacies from providing drug price information to customers.

The Department of Justice approved the $69 billion CVS-Aetna merger under conditions designed to preserve competition in the marketplace.

A new combination treatment that targets the latent reservoir of HIV may be a potential effective therapeutic strategy.

Top news of the day from across the health care landscape.

Partnering with a physician to deliver chronic care can be an important way for pharmacists to not only better service patents, but also derive additional revenue.

Study highlights mechanism of endocrine resistance in estrogen receptor-positive breast cancers and potential therapeutic targets.

Glecaprevir/pibrentasvir found to be effective in clinical trials treating patients with hepatitis C virus also being treated for opioid substitution therapy.

Specialty medications are still mostly branded products, but patients remain hesitant to accept less expensive generic alternatives when the option is available.

The study points to the importance of screening for and treating arthritis-related pain in older adults with varying degrees of depression.